Innovative strategy and characterization protocol of nanoparticle carriers drug delivery system through mucosa barrier

Journal of International Pharmaceutical Research

Volumn 37, Issue 6, 2010, Pages

  Lin, Dong Hai ^a   Li, Gang ^a   Sun, Xiu Yan ^a  

^a YANTAI UNIVERSITY   (China)

Author keywords

Diffusion; Mucosa; Mucus; Mucus penetrating particles; Multiple particle tracking; Nanoparticle

Indexed keywords

MUCUS PENETRATING PARTICLE; NANOCARRIER; UNCLASSIFIED DRUG;

CYTOPLASM; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; MUCUS; MULTIPLE PARTICLE TRACKING; PERMEABILITY BARRIER; REVIEW;

EID: 78651321212     PISSN: 16740440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Khanvilkar K, Donovan MD, Flanagan DR. Drug transfer through mucus[J]. Adv Drug Deliv Rev, 2001, 48(2/3): 173-193.
2. Davidovich-Pinhas M, Harari O, Bianco-Peled H. Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate[J]. J Control Release, 2009, 136(1): 38-44.
3. Montisci MJ, Dembri A, Giovannuci G, et al. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats[J]. Pharm Res, 2001, 18(6): 829-837.
4. Lai SK, Wang YY, Wirtz D, et al. Micro- and macrorheology of mucus[J]. Adv Drug Deliv Rev, 2009, 61(2): 86-100.
5. Clunes MT, Boucher RC. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder[J]. Drug Discov Today Dis Mech, 2007, 4(2): 63-72.
6. Jordan N, Newton J, Pearson J, et al. A novel method for the visualization of the in situ mucus layer in rat and man[J]. Clin Sci (Lond), 1998, 95(1): 97-106.
7. Boatsman JE, Calhoun KH, Ryan MW. Relationship between rhinosinusitis symptoms and mucociliary clearance time[J]. Otolaryngol Head Neck Surg, 2006, 134(3): 491-493.
8. Greaves JL, Wilson CG. Treatment of diseases of the eye with mucoadhesive delivery systems[J]. Adv Drug Deliv Rev, 1993, 11(3): 349-383.
9. Mainardes RM, Urban MC, Cinto PO, et al. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery [J]. Curr Drug Deliv, 2006, 3(3): 275-285.
10. Cone RA. Barrier properties of mucus[J]. Adv Drug Deliv Rev, 2009, 61(2): 75-85.
11. Olmsted SS, Padgett JL, Yudin AI, et al. Diffusion of macromolecules and virus-like particles in human cervical mucus [J]. Biophys J, 2001, 81(4): 1930-1937.
12. Suh J , Dawson M , Hanes J. Real-time multiple-particle tracking: applications to drug and gene delivery[J]. Adv Drug Deliv Rev, 2005, 57(1): 63-78.
13. Suh J, Choy KL, Lai SK, et al. PEGylation of nanoparticles improves their cytoplasmic transport[J]. Int J Nanomed, 2007, 2(4): 735-741.
14. Dawson M , Wirtz D , Hanes J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport[J]. J Biol Chem, 2003, 278(50): 50393-50401.
15. Dawson M, Krauland E, Wirtz D, et al. Transport of polymeric nanoparticle gene carriers in gastric mucus[J]. Biotechnol Prog, 2004, 20(3): 851-857.
16. Saltzman WM, Radomsky ML, Whaley KJ, et al. Antibody dillusion in human cervical mucus[J]. Biophys J, 1994, 66(2 Pt 1): 508-515.
17. Lai SK, O'Hanlon DE, Harrold S, et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus [J]. Proc Natl Acad Sci USA, 2007, 104(5): 1482-1487.
18. Wang YY, Lai SK, Suk JS, et al. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier[J]. Angew Chem Int Ed Engl, 2008, 47(50): 9726-9729.
19. Cu Yen, Saltzman WM. Controlled surface modification with poly (ethylene)glycol enhances diffusion of pLGA nanoparticles in human cervical mucus[J]. Mol Pharm, 2009, 6(1): 173-181